If you are currently on the maximum tolerated dosage of your medication, and still experiencing symptoms of angina and myocardial ischemia, you’re invited to see if you may qualify for the Renew Study. The purpose of the study is to determine the safety and effectiveness of an investigational therapy using a patient’s own stem cells for the treatment of angina symptoms.
Each individual must be 21 or older, and will be evaluated to determine his or her eligibility. Qualified participants will receive either the investigational therapy or placebo, or continue with current approved angina treatment options, providing researchers with a standard comparison to the investigational therapy. All participants will receive study-related medical exams and lab tests at no charge. Compensation for time and travel may be available.
For more information, click here.
A disease of heart function characterized by inadequate blood flow to the muscle tissue of the heart.